Article Details

Argenx Makes $1.5B+ Play for UNP's Macrocyclic Peptides Aimed at 'Undruggable' Targets

Retrieved on: 2025-07-01 13:30:36

Tags for this article:

Click the tags to see associated articles and topics

Argenx Makes $1.5B+ Play for UNP's Macrocyclic Peptides Aimed at 'Undruggable' Targets. View article details on hiswai:

Excerpt

... peptide space. Argenx has also pledged to participate in UNP's ... The biotech is also working on the complement blocker empasiprubart for ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo